AKT1 and acute lymphoblastic leukemia: Moreover, in T-ALL many of the metabolic regulators that allow metabolic adaptation such as PI3K/AKT/mTOR, NOTCH1, c-MYC, AMPK, and HIF-1 are frequently deregulated, leading these cells to exhibit increased glucose consumption and increased glycolysis [244].